Furthermore, the toxicity was higher in DLBCL cells compared to non‐malignant cells except for the combination of DNA‐PK/doxorubicin, which showed similar toxicity in both compartments (Figure S8). Here, PRKDC is linked to diffuse large B-cell lymphoma.